Viewing Study NCT04566692


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-01-05 @ 5:44 PM
Study NCT ID: NCT04566692
Status: COMPLETED
Last Update Posted: 2023-09-29
First Post: 2020-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency
Sponsor: Grifols Therapeutics LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GC1906
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators